Private company
Who owns Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures)
One company in the researched set discloses a stake in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), worth $2.50bn between them. Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures) is private, so no 13F reports it: a 13F covers exchange listed positions only. These figures exist because each holder disclosed the stake in its own filings.
The disclosed stakes
One row per position. Where a holder reports the same company in two share classes, both rows are shown rather than summed, because the class is part of a position's identity.
Where each figure comes from
A private stake has no ownership form behind it, so the source is always the holder's own filing or disclosure. Anything modelled says so, with the arithmetic.
- McKesson Corporation, as of 2 Jun 2025. Core Ventures is an LLC; membership interests are not share denominated, so shares is left null. The value is the cash consideration paid at closing (2 June 2025), not a subsequent fair value remeasurement. McKesson consolidates Core Ventures as the controlling owner; the remaining 30 percent is a redeemable noncontrolling interest held by Florida Cancer Specialists & Research Institute, LLC (FCS), the entity that established Core Ventures. sourcesource 2
What this page is not
It is not a complete register. It lists the holders who happen to be inside the researched set and disclosed the stake themselves. A private company can have many other shareholders, and nothing here rules them out: venture investors, founders and employees usually appear in no public filing at all. Percentages are of Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures) where a holder stated one, and are missing where no holder did.